IGMS Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-03-14 | Takimoto Chris H | officer: Chief Medical Officer | 28,789 | S-Sale | D | 1,768 | 18.73 | 33,118.18 |
| 2023-03-14 | Keyt Bruce | officer: Chief Scientific Officer | 90,704 | S-Sale | D | 1,293 | 18.73 | 24,220.48 |
| 2023-03-14 | Tahir Misbah | officer: Chief Financial Officer | 25,322 | S-Sale | D | 1,768 | 18.73 | 33,118.18 |
| 2023-03-14 | Decker Lisa Lynn | officer: Chief Business Officer | 16,732 | S-Sale | D | 1,061 | 18.73 | 19,874.65 |
| 2023-03-14 | Gauthier George | officer: Chief Commercial Officer | 18,563 | S-Sale | D | 1,061 | 18.73 | 19,874.65 |
| 2023-01-05 | Keyt Bruce | officer: Chief Scientific Officer | 0 | M-Exempt | D | 33,756 | 0.93 | 31,393.08 |
| 2023-01-05 | Keyt Bruce | officer: Chief Scientific Officer | 91,997 | M-Exempt | A | 33,756 | 0.93 | 31,393.08 |
| 2022-12-30 | Lee Michael Stewart | director | 2,152 | A-Award | A | 230 | 0.00 | 0.00 |
| 2022-12-30 | Redmile Group, LLC | director, 10 percent owner | 3,336,507 | A-Award | A | 230 | 0.00 | 0.00 |
| 2022-12-30 | Topsoe Jakob Haldor | director, 10 percent owner | 74,152 | A-Award | A | 230 | 0.00 | 0.00 |
| 2022-12-30 | BEHRENS M KATHLEEN | director | 3,768 | A-Award | A | 374 | 0.00 | 0.00 |
| 2022-12-30 | LOBERG MICHAEL D | director | 533 | A-Award | A | 533 | 0.00 | 0.00 |
| 2022-12-30 | Topsoe Christina Teng | director, 10 percent owner | 37,967 | A-Award | A | 346 | 0.00 | 0.00 |
| 2022-12-19 | Tahir Misbah | officer: Chief Financial Officer | 27,090 | S-Sale | D | 3,801 | 20.00 | 76,020.00 |
| 2022-12-16 | Takimoto Chris H | officer: Chief Medical Officer | 30,557 | S-Sale | D | 1,938 | 19.36 | 37,518.71 |
| 2022-12-16 | Takimoto Chris H | officer: Chief Medical Officer | 32,495 | S-Sale | D | 3,492 | 18.77 | 65,560.90 |
| 2022-12-16 | Keyt Bruce | officer: Chief Scientific Officer | 58,241 | S-Sale | D | 1,917 | 19.36 | 37,112.16 |
| 2022-12-16 | Keyt Bruce | officer: Chief Scientific Officer | 60,158 | S-Sale | D | 3,454 | 18.77 | 64,847.47 |
| 2022-12-16 | Schwarzer Fred | director, officer: CEO and President | 20,360 | S-Sale | D | 4,414 | 19.36 | 85,452.83 |
| 2022-12-16 | Schwarzer Fred | director, officer: CEO and President | 24,774 | S-Sale | D | 7,955 | 18.77 | 149,351.94 |
| 2022-12-16 | Tahir Misbah | officer: Chief Financial Officer | 30,891 | S-Sale | D | 815 | 19.36 | 15,777.99 |
| 2022-12-16 | Tahir Misbah | officer: Chief Financial Officer | 31,706 | S-Sale | D | 1,468 | 18.77 | 27,561.11 |
| 2022-12-16 | Decker Lisa Lynn | officer: Chief Business Officer | 17,793 | S-Sale | D | 886 | 19.36 | 17,152.52 |
| 2022-12-16 | Decker Lisa Lynn | officer: Chief Business Officer | 18,679 | S-Sale | D | 1,598 | 18.77 | 30,001.81 |
| 2022-12-16 | Gauthier George | officer: Chief Commercial Officer | 19,624 | S-Sale | D | 1,554 | 19.36 | 30,084.66 |
| 2022-12-16 | Gauthier George | officer: Chief Commercial Officer | 21,178 | S-Sale | D | 2,800 | 18.77 | 52,568.88 |
| 2022-12-14 | Keyt Bruce | officer: Chief Scientific Officer | 33,756 | M-Exempt | D | 25,000 | 0.93 | 23,250.00 |
| 2022-12-14 | Keyt Bruce | officer: Chief Scientific Officer | 63,612 | M-Exempt | A | 25,000 | 0.93 | 23,250.00 |
| 2022-11-23 | Takimoto Chris H | officer: Chief Medical Officer | 35,987 | S-Sale | D | 277 | 21.99 | 6,091.62 |
| 2022-11-23 | Takimoto Chris H | officer: Chief Medical Officer | 36,264 | S-Sale | D | 600 | 21.38 | 12,825.90 |
| 2022-11-23 | Decker Lisa Lynn | officer: Chief Business Officer | 20,277 | S-Sale | D | 397 | 21.99 | 8,730.59 |
| 2022-11-23 | Decker Lisa Lynn | officer: Chief Business Officer | 20,674 | S-Sale | D | 861 | 21.38 | 18,405.17 |
| 2022-11-23 | Gauthier George | officer: Chief Commercial Officer | 23,978 | S-Sale | D | 397 | 21.99 | 8,730.59 |
| 2022-11-23 | Gauthier George | officer: Chief Commercial Officer | 24,375 | S-Sale | D | 861 | 21.38 | 18,405.17 |
| 2022-11-23 | Keyt Bruce | officer: Chief Scientific Officer | 38,612 | S-Sale | D | 277 | 21.99 | 6,091.62 |
| 2022-11-23 | Keyt Bruce | officer: Chief Scientific Officer | 38,889 | S-Sale | D | 600 | 21.38 | 12,825.90 |
| 2022-11-23 | Schwarzer Fred | director, officer: CEO and President | 32,729 | S-Sale | D | 397 | 21.99 | 8,730.59 |
| 2022-11-23 | Schwarzer Fred | director, officer: CEO and President | 33,126 | S-Sale | D | 861 | 21.38 | 18,405.17 |
| 2022-11-23 | Tahir Misbah | officer: Chief Financial Officer | 33,174 | S-Sale | D | 277 | 21.99 | 6,091.62 |
| 2022-11-23 | Tahir Misbah | officer: Chief Financial Officer | 33,451 | S-Sale | D | 600 | 21.38 | 12,825.90 |
| 2022-11-15 | Tahir Misbah | officer: Chief Financial Officer | 34,051 | A-Award | A | 353 | 12.84 | 4,532.52 |
| 2022-11-08 | BEHRENS M KATHLEEN | director | 218,200 | P-Purchase | A | 60,000 | 17.14 | 1,028,550.00 |
| 2022-10-14 | LOBERG MICHAEL D | director | 35,838 | G-Gift | A | 533 | 0.00 | 0.00 |
| 2022-10-14 | LOBERG MICHAEL D | director | 0 | G-Gift | D | 533 | 0.00 | 0.00 |
| 2022-10-04 | Keyt Bruce | officer: Chief Scientific Officer | 58,756 | M-Exempt | D | 25,000 | 0.93 | 23,250.00 |
| 2022-10-04 | Keyt Bruce | officer: Chief Scientific Officer | 39,489 | S-Sale | D | 25,000 | 22.84 | 570,980.00 |
| 2022-10-04 | Keyt Bruce | officer: Chief Scientific Officer | 64,489 | M-Exempt | A | 25,000 | 0.93 | 23,250.00 |
| 2022-10-03 | Redmile Group, LLC | director, 10 percent owner | 667,666 | J-Other | D | 16,375 | 0.01 | 163.75 |
| 2022-10-03 | Redmile Group, LLC | director, 10 percent owner | 4,500,225 | J-Other | D | 297,801 | 22.49 | 6,697,544.49 |
| 2022-10-03 | Redmile Group, LLC | director, 10 percent owner | 3,336,277 | J-Other | A | 221,072 | 22.49 | 4,971,909.28 |
| 2022-09-30 | Redmile Group, LLC | director, 10 percent owner | 3,336,277 | A-Award | A | 230 | 0.00 | 0.00 |
| 2022-09-30 | Lee Michael Stewart | director | 1,922 | A-Award | A | 230 | 0.00 | 0.00 |
| 2022-09-30 | Topsoe Jakob Haldor | director, 10 percent owner | 73,922 | A-Award | A | 230 | 0.00 | 0.00 |
| 2022-09-30 | Topsoe Christina Teng | director, 10 percent owner | 37,621 | A-Award | A | 346 | 0.00 | 0.00 |
| 2022-09-30 | BEHRENS M KATHLEEN | director | 3,394 | A-Award | A | 374 | 0.00 | 0.00 |
| 2022-09-30 | LOBERG MICHAEL D | director | 533 | A-Award | A | 533 | 0.00 | 0.00 |
| 2022-09-29 | LOBERG MICHAEL D | director | 35,305 | P-Purchase | A | 5,821 | 19.62 | 114,212.68 |
| 2022-09-28 | LOBERG MICHAEL D | director | 29,484 | P-Purchase | A | 6,172 | 20.97 | 129,402.77 |
| 2022-09-27 | LOBERG MICHAEL D | director | 23,312 | P-Purchase | A | 507 | 19.99 | 10,136.70 |
| 2022-09-08 | Keyt Bruce | officer: Chief Scientific Officer | 83,756 | M-Exempt | D | 10,000 | 0.93 | 9,300.00 |
| 2022-09-08 | Keyt Bruce | officer: Chief Scientific Officer | 39,489 | S-Sale | D | 2,735 | 20.34 | 55,631.81 |
| 2022-09-08 | Keyt Bruce | officer: Chief Scientific Officer | 42,224 | S-Sale | D | 7,265 | 19.57 | 142,195.67 |
| 2022-09-08 | Keyt Bruce | officer: Chief Scientific Officer | 49,489 | M-Exempt | A | 10,000 | 0.93 | 9,300.00 |
| 2022-09-07 | Keyt Bruce | officer: Chief Scientific Officer | 93,756 | M-Exempt | D | 10,000 | 0.93 | 9,300.00 |
| 2022-09-07 | Keyt Bruce | officer: Chief Scientific Officer | 39,489 | S-Sale | D | 10,000 | 19.04 | 190,392.00 |
| 2022-09-07 | Keyt Bruce | officer: Chief Scientific Officer | 49,489 | M-Exempt | A | 10,000 | 0.93 | 9,300.00 |
| 2022-09-06 | Keyt Bruce | officer: Chief Scientific Officer | 103,756 | M-Exempt | D | 5,000 | 0.93 | 4,650.00 |
| 2022-09-06 | Keyt Bruce | officer: Chief Scientific Officer | 39,489 | S-Sale | D | 5,000 | 19.06 | 95,321.00 |
| 2022-09-06 | Keyt Bruce | officer: Chief Scientific Officer | 44,489 | M-Exempt | A | 5,000 | 0.93 | 4,650.00 |
| 2022-08-22 | Keyt Bruce | officer: Chief Scientific Officer | 108,756 | M-Exempt | D | 6,300 | 0.93 | 5,859.00 |
| 2022-08-22 | Keyt Bruce | officer: Chief Scientific Officer | 39,489 | S-Sale | D | 6,300 | 20.71 | 130,450.95 |
| 2022-08-22 | Keyt Bruce | officer: Chief Scientific Officer | 45,789 | M-Exempt | A | 6,300 | 0.93 | 5,859.00 |
| 2022-08-19 | Keyt Bruce | officer: Chief Scientific Officer | 115,056 | M-Exempt | D | 8,700 | 0.93 | 8,091.00 |
| 2022-08-19 | Keyt Bruce | officer: Chief Scientific Officer | 39,489 | S-Sale | D | 8,700 | 22.82 | 198,544.44 |
| 2022-08-19 | Keyt Bruce | officer: Chief Scientific Officer | 48,189 | M-Exempt | A | 8,700 | 0.93 | 8,091.00 |
| 2022-08-18 | Keyt Bruce | officer: Chief Scientific Officer | 123,756 | M-Exempt | D | 10,000 | 0.93 | 9,300.00 |
| 2022-08-18 | Keyt Bruce | officer: Chief Scientific Officer | 39,489 | S-Sale | D | 10,000 | 22.54 | 225,352.00 |
| 2022-08-18 | Keyt Bruce | officer: Chief Scientific Officer | 49,489 | M-Exempt | A | 10,000 | 0.93 | 9,300.00 |
| 2022-07-18 | LOBERG MICHAEL D | director | 22,805 | G-Gift | A | 533 | 0.00 | 0.00 |
| 2022-07-18 | LOBERG MICHAEL D | director | 0 | G-Gift | D | 533 | 0.00 | 0.00 |
| 2022-06-30 | Lee Michael Stewart | director | 1,692 | A-Award | A | 230 | 0.00 | 0.00 |
| 2022-06-30 | Redmile Group, LLC | director, 10 percent owner | 3,336,047 | A-Award | A | 230 | 0.00 | 0.00 |
| 2022-06-30 | Topsoe Jakob Haldor | director, 10 percent owner | 73,692 | A-Award | A | 230 | 0.00 | 0.00 |
| 2022-06-30 | Topsoe Christina Teng | director, 10 percent owner | 37,275 | A-Award | A | 346 | 0.00 | 0.00 |
| 2022-06-30 | BEHRENS M KATHLEEN | director | 3,020 | A-Award | A | 374 | 0.00 | 0.00 |
| 2022-06-30 | LOBERG MICHAEL D | director | 533 | A-Award | A | 533 | 0.00 | 0.00 |
| 2022-05-26 | Tahir Misbah | officer: Chief Financial Officer | 33,698 | S-Sale | D | 950 | 17.10 | 16,247.47 |
| 2022-05-24 | Schwarzer Fred | director, officer: CEO and President | 33,987 | S-Sale | D | 1,362 | 17.10 | 23,293.74 |
| 2022-05-24 | Gauthier George | officer: Chief Commercial Officer | 25,236 | S-Sale | D | 1,340 | 17.10 | 22,916.95 |
| 2022-05-24 | Keyt Bruce | officer: Chief Scientific Officer | 39,489 | S-Sale | D | 939 | 17.10 | 16,058.31 |
| 2022-05-24 | Takimoto Chris H | officer: Chief Medical Officer | 36,864 | S-Sale | D | 938 | 17.10 | 16,043.46 |
| 2022-05-24 | Decker Lisa Lynn | officer: Chief Business Officer | 21,535 | S-Sale | D | 1,362 | 17.10 | 23,293.33 |
| 2022-05-20 | Topsoe Jakob Haldor | director, 10 percent owner | 73,462 | P-Purchase | A | 1,481 | 16.00 | 23,696.00 |
| 2022-05-13 | Takimoto Chris H | officer: Chief Medical Officer | 37,802 | A-Award | A | 825 | 12.38 | 10,213.50 |
| 2022-05-13 | Tahir Misbah | officer: Chief Financial Officer | 34,648 | A-Award | A | 391 | 12.38 | 4,840.58 |
| 2022-05-13 | Topsoe Christina Teng | director, 10 percent owner | 6,800 | P-Purchase | A | 4,510 | 14.99 | 67,593.17 |
| 2022-05-13 | Topsoe Jakob Haldor | director, 10 percent owner | 71,981 | P-Purchase | A | 7,850 | 14.86 | 116,683.18 |
| 2022-05-13 | Decker Lisa Lynn | officer: Chief Business Officer | 22,897 | A-Award | A | 413 | 12.38 | 5,112.94 |
| 2022-05-13 | Gauthier George | officer: Chief Commercial Officer | 26,576 | A-Award | A | 413 | 12.38 | 5,112.94 |
| 2022-05-13 | Keyt Bruce | officer: Chief Scientific Officer | 40,428 | A-Award | A | 413 | 12.38 | 5,112.94 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.